ArticleCureus2024
Intracranial Myeloid Sarcoma Arising Intra-axially From Acute Myeloid Leukemia: A Case Report and Literature Review.
Article in Cureus, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Myeloid sarcoma of the septum pellucidum causing hallucinations and personality changes in an elderly woman: a case report.Annals of hematology · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
10 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Intracranial myeloid sarcoma is a rare brain tumor and an extramedullary manifestation of malignant hematopoietic neoplasms of myeloid origin. A 76-year-old right-handed male patient was initially diagnosed with acute myeloid leukemia (AML; M4Eo). Three years later, the patient experienced headaches, dizziness, nausea, and gait disturbances. Magnetic resonance imaging of the head revealed a mass lesion that appeared to be extra-axial in the right cerebellum with well-defined borders that did not show contrast enhancement and was in contact with the dura mater. The patient underwent surgical tumor resection using the lateral suboccipital approach. The tumor did not attach to the dura mater, indicating susceptibility of an intra-axial tumor. Complete tumor resection was performed. The intraoperative pathological diagnosis revealed the involvement of AML characterized by small round cells diffusely increasing in size with angiogenesis and invasion of macrophages. In conclusion, we present a rare case of intracranial myeloid sarcoma arising intra-axially and originating from an AML that was treated with surgical tumor resection. Although it is difficult to determine whether the tumor was extra-axial or intra-axial on imaging, intracranial myeloid sarcoma should be considered as a differential disease when the patient has a history of hematological neoplasia, such as AML.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.